Thomas Cheng
Impact in
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Wnt/β-catenin signaling in development and cancer 2
- Epigenetics and DNA Methylation 2
- DNA Repair Mechanisms 1
- Ubiquitin and proteasome pathways 1
- FOXO transcription factor regulation 1
- Oncology 6
- Cancer Cells and Metastasis 2
- Co-authors
- David W. C. Yeung (1 shared paper)Sihan Chen (1 shared paper)Khoa Nguyen (7 shared papers)Matthew E. Burow (6 shared papers)Bridgette M. Collins‐Burow (6 shared papers)Sirong Chen (5 shared papers)Chi-Lai Ho (5 shared papers)Raymond Liang (1 shared paper)
- Journals
- Journal of Nuclear Medicine (1 paper)Oncogene (1 paper)Biomedicine & Pharmacotherapy (1 paper)Cancers (1 paper)
- Partner nations
- United StatesHong KongIran
In The Last Decade
Thomas Cheng
12 papers receiving 284 citations
Peers
Comparison fields: 5 of 49
- Hepatology 88
- Cancer Research 51
- Hematology 37
- Oncology 76
- Radiology, Nuclear Medicine and Imaging 59
Countries citing papers authored by Thomas Cheng
This map shows the geographic impact of Thomas Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Cheng more than expected).
Fields of papers citing papers by Thomas Cheng
This network shows the impact of papers produced by Thomas Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Cheng. The network helps show where Thomas Cheng may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 157 | |
| 2 | 2014 | 42 | |
| 3 | 2021 | 26 | |
| 4 | 2022 | 18 | |
| 5 | 2023 | 14 | |
| 6 | 2022 | 14 | |
| 7 | 2022 | 11 | |
| 8 | 2023 | 8 | |
| 9 | Dual-tracer PET/CT for the differential diagnosis of small liver nodules (1-2 cm) in cirrhosis: Early HCC or dysplastic nodule? | 2012 | 1 |
| 10 | 2022 | 1 | |
| 11 | 2015 | 1 | |
| 12 | Functional analysis of 18F-DOPA PET for the diagnosis of Parkinson's disease | 2012 | 1 |
| 13 | 2011 | 0 | |
| 14 | Added value of 11C-acetate PET/CT to 18F-FDG for the management of myeloma | 2012 | 0 |
About Thomas Cheng
Thomas Cheng is a scholar working on Molecular Biology, Oncology, Hepatology, Genetics and Neurology, having authored 14 papers that have together received 294 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Cancer Cells and Metastasis (2 papers), Wnt/β-catenin signaling in development and cancer (2 papers), Epigenetics and DNA Methylation (2 papers), DNA Repair Mechanisms (1 paper), Ubiquitin and proteasome pathways (1 paper), MRI in cancer diagnosis (1 paper) and FOXO transcription factor regulation (1 paper). The work is most often cited by research in Hepatology (88 citations), Cancer Research (51 citations), Hematology (37 citations), Oncology (76 citations) and Radiology, Nuclear Medicine and Imaging (59 citations). Thomas Cheng has collaborated with scholars based in United States, Hong Kong and Iran. Frequent co-authors include David W. C. Yeung, Sihan Chen, Khoa Nguyen, Matthew E. Burow, Bridgette M. Collins‐Burow, Sirong Chen, Chi-Lai Ho, Raymond Liang, Chor Sang Chim and David H. Drewry. Their work appears in journals such as Journal of Nuclear Medicine, Oncogene, Journal of Nuclear Medicine, Biomedicine & Pharmacotherapy and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.